Literature DB >> 2257061

Decreased uptake and binding of 11C-nicotine in brain of Alzheimer patients as visualized by positron emission tomography.

A Nordberg1, P Hartvig, A Lilja, M Viitanen, K Amberla, H Lundqvist, Y Andersson, J Ulin, B Winblad, B Långström.   

Abstract

Positron emission tomography of the brain following intravenous injection of (+) (R) and (-) (S) N-[11C-methyl]nicotine showed a marked reduced uptake of both isomers, especially the (R) form, in Alzheimer patients as compared to age-matched controls. The significantly larger difference between the uptake values of the (S)- and (R)-enantiomers of 11C-nicotine in Azheimer brains may be of diagnostic value.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2257061     DOI: 10.1007/bf02257652

Source DB:  PubMed          Journal:  J Neural Transm Park Dis Dement Sect        ISSN: 0936-3076


  22 in total

1.  Smoking produces rapid rise of [11C]nicotine in human brain.

Authors:  Marc S Berridge; Scott M Apana; Kenichi K Nagano; Catherine E Berridge; Gregory P Leisure; Mark V Boswell
Journal:  Psychopharmacology (Berl)       Date:  2010-03-16       Impact factor: 4.530

2.  Development and optimization of a novel automated loop method for production of [11C]nicotine.

Authors:  Arijit Ghosh; Karen Woolum; Michael V Knopp; Krishan Kumar
Journal:  Appl Radiat Isot       Date:  2018-05-30       Impact factor: 1.513

3.  Radioiodination of nicotine with specific activity high enough for mapping nicotinic acetylcholine receptors.

Authors:  I Kämpfer; D Sorger; R Schliebs; W Kärger; K Günther; K Schulze; W H Knapp
Journal:  Eur J Nucl Med       Date:  1996-02

4.  PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease.

Authors:  Ahmadul Kadir; Ove Almkvist; Anders Wall; Bengt Långström; Agneta Nordberg
Journal:  Psychopharmacology (Berl)       Date:  2006-07-11       Impact factor: 4.530

5.  A comparison of the binding of nicotine and nornicotine stereoisomers to nicotinic binding sites in rat brain cortex.

Authors:  J R Copeland; A Adem; P Jacob; A Nordberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-02       Impact factor: 3.000

Review 6.  The application of positron-emitting molecular imaging tracers in Alzheimer's disease.

Authors:  Robert M Cohen
Journal:  Mol Imaging Biol       Date:  2007 Jul-Aug       Impact factor: 3.488

7.  Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[18F]fluoro-A-85380 PET.

Authors:  J R Ellis; P J Nathan; V L Villemagne; R S Mulligan; T Saunder; K Young; C L Smith; J Welch; M Woodward; K A Wesnes; G Savage; C C Rowe
Journal:  Psychopharmacology (Berl)       Date:  2008-10-24       Impact factor: 4.530

Review 8.  Acetylcholine receptors in dementia and mild cognitive impairment.

Authors:  Osama Sabri; Kai Kendziorra; Henrike Wolf; Hermann-Josef Gertz; Peter Brust
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 9.236

Review 9.  Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer's disease and Parkinson's disease.

Authors:  J R James; A Nordberg
Journal:  Behav Genet       Date:  1995-03       Impact factor: 2.805

10.  Application of carbon-11 labelled nicotine in the measurement of human cerebral blood flow and other physiological parameters.

Authors:  F Yokoi; T Komiyama; T Ito; T Hayashi; M Lio; T Hara
Journal:  Eur J Nucl Med       Date:  1993-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.